Cargando…
Bacterial outer membrane vesicle-based cancer nanovaccines
Tumor vaccines, a type of personalized tumor immunotherapy, have developed rapidly in recent decades. These vaccines evoke tumor antigen-specific T cells to achieve immune recognition and killing of tumor cells. Because the immunogenicity of tumor antigens alone is insufficient, immune adjuvants and...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Compuscript
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500226/ https://www.ncbi.nlm.nih.gov/pubmed/36172794 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0452 |